Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
T.MDP
Alternate Symbol(s):
MEDXF
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its...
lead products are IXINITY (US), Rupall (Canada), Rasuvo (US) and Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Mar 03, 2021 10:41am
Analyst Upgrade
Following the release of in-line third-quarter 2021 results, Canaccord Genuity analyst Tania Gonsalves sees a recent dip in shares of Medexus Pharmaceuticals Inc. ( MDP-X +4.60%increase ) as a
...more
(2)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Mar 03, 2021 10:38am
RE:RE:RE:RE:RE:RE:Numbers out. Very nice
patience needed....I expect to hear Nasdaq news in next week or so...Usually takes 4- 6 weeks
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Mar 02, 2021 4:11pm
RE:RE:RE:RE:RE:Numbers out. Very nice
Big news on earnings and very tepid reaction with low volume. Definitely need to move to the Nasdaq. If it goes to $7 I'm buying more.
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Mar 02, 2021 10:01am
RE:RE:RE:RE:Numbers out. Very nice
Nothing concrete on nasdaq listing other than the application is being processed. I'd think some time in april medxf will be listed
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Mar 02, 2021 9:43am
RE:RE:RE:Numbers out. Very nice
Nevermind I figured it out myself. Sweet deal for the debenture holder. I hope they converted everything. Could be why the stock went down over the last 2 weeks. Fantastic results as sales almost
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Mar 02, 2021 9:16am
RE:RE:Numbers out. Very nice
Excellent Revenue numbers and expenses are down. Can anyone eplain this to me: With the significant share price appreciation in the quarter, the non-cash fair value of the derivative associated with
...more
(50)
•••
snootchybootchy
X
View Profile
View Bullboard History
Comment by
snootchybootchy
on Mar 02, 2021 2:12am
RE:RE:Numbers out. Very nice
I have a feeling this stock will be trading at $9+ tomorrow.
(2)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Mar 01, 2021 8:21pm
RE:Numbers out. Very nice
They Rock!!!!! Great report....
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Comment by
Finallytherock
on Mar 01, 2021 5:04pm
RE:RE:RE:RE:More product equal more revenue
here you go https://www.medexus.com/en_US/news-media/press-releases/detail/71/medexus-achieves-record-revenue-of-31-5-million-for-the
(751)
•••
Finallytherock
X
View Profile
View Bullboard History
Post by
Finallytherock
on Mar 01, 2021 5:04pm
Numbers out. Very nice
https://www.medexus.com/en_US/news-media/press-releases/detail/71/medexus-achieves-record-revenue-of-31-5-million-for-the
(2)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Mar 01, 2021 5:01pm
RE:RE:RE:More product equal more revenue
Well 7 is a good number and a generous offer to amny to either get into a position here or add more shares...Once this paper is given green light, it's gonna reward us..When this happens, we will
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Mar 01, 2021 4:25pm
RE:RE:More product equal more revenue
I think the report would have to be good otherwise why announce going to the Nasdaq. Too many good things happening here for this stock to be at $7. Not sure why that is but I hope that tomorrow were
...more
(2)
•••
oceaneleven
X
View Profile
View Bullboard History
Comment by
oceaneleven
on Mar 01, 2021 3:39pm
RE:More product equal more revenue
I'll be wayching Sedar filings today after close and of course financials tomorrow.. I think they will be extra good!!!
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Mar 01, 2021 10:53am
More product equal more revenue
Medexus Pharmaceuticals Inc (TSXV:MDP.VN) (OTCQX:MEDXF) (FRA:P731) begins commercial launch of tumor imaging powder Gleolan in Canada
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Mar 01, 2021 10:51am
RE:I am still holding onto my shares.
The company is run by some really savvy industry veterans. They have products lined up to sell. They have had analysts upgrades and are heading for listing on Nasdaq. Okay "so what", you
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >